SynthImmune PIs Frauke Mücksch and Oliver Fackler discuss the recent paper from MIT’s Mark Bathe’s lab on DNA origami vaccines in a research highlight in the journal Signal Transduction and Targeted Therapy. The paper presents a prototype DNA origami scaffold that may enhance HIV vaccine strategies, an important step as HIV remains without a licensed vaccine despite decades of research. DNA origami-based treatments are part of SynthImmune‘s research program, and this paper demonstrates their enormous potential for further optimization of vaccine efficacy and breadth.
Mark Bathe had recently attended the annual meeting of the Society of Virology. He presented his work on DNA origami vaccines in the plenary session on synthetic & novel approaches in virology, co-hosted by SynthImmune PIs Oliver Fackler and Athanasios Typas.
Read the full research highlight here.
